Recent Updates
Recently added Catalysts
LXRX Positive Sentiment

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Thursday, May 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lexicon Pharmaceuticals will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026. The event will take place in New York City at 2:00 p.m. ET. Attendees can access the live event and replay via the company's website. Lexicon focuses on developing innovative medicines for various medical conditions.
Price reaction · baseline $2.17 (2026-05-27 close) · hit after-hours · clean, no other LXRX news in the window
day 0 close · peak
+1.8%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Lexicon Pharmaceuticals will present at a notable healthcare conference.
  • The event showcases the company's commitment to transparency and engagement.
  • The company has a diverse pipeline targeting significant health issues.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus

Full Press Release Details

THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) --Lexicon Pharmaceuticals, Inc.(Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 2:00 p.m. ET in New York City.
The live event and a replay of the presentation can be accessed via the Events page of the Company’s website athttps://investors.lexpharma.com/.
About Lexicon PharmaceuticalsLexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visitwww.lexpharma.com.
For Media Inquiries:Dave BelianLexicon Pharmaceuticals, Inc.lexinvest@lexpharma.comFor Investor Inquiries:Lisa DeFrancescoLexicon Pharmaceuticals, Inc.lexinvest@lexpharma.com

Frequently Asked Questions

When will Lexicon Pharmaceuticals present at the conference?

Lexicon Pharmaceuticals will present on June 4, 2026, at 2:00 p.m. ET.

Where is the 2026 Jefferies Global Healthcare Conference held?

The conference will take place in New York City.

How can I access the presentation?

The live event and replay can be accessed via Lexicon's Events page.

What is Lexicon Pharmaceuticals focused on?

Lexicon develops medicines for neuropathic pain, HCM, obesity, and metabolic disorders.

ShareAdd on Google
Tags: LXRX Viatris Investor Conferences Healthcare Jefferies Global Healthcare Conference biopharmaceuticals clinical development neuropathic pain
Last updated: May 28, 2026

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$191M liquidity · $3M/mo burn
~61 mo
Minimal dilution risk
Lead asset
SotagliflozinPhase 3
Type 1 Diabetes Mellitus →

Catalyst track record

+111%
best trade around LXRX's most recent catalyst

Peak hindsight return over a 120-day window, across 13 tracked FDA/PDUFA catalysts for LXRX.

See every catalyst's timing & PoA →